Specific binding sites for human luteinizing hormone in Neurospora crassa and Saccharomyces cerevisiae

T. A. Bramley, G. S. Menzies, R. J. Williams, O. S. Kinsman, D. J. Adams

Research output: Contribution to journalArticlepeer-review

Abstract

Specific binding sites for 125I-labelled human luteinizing hormone (hLH) were detected in microsomal and cytosolic fractions from Saccharomyces cerevisiae, Neurospora crassa and a wall-less (‘slime’) mutant of N. crassa. Scatchard analysis of hLH-binding to microscomes revealed the presence of both high affinity (Ka of 60–70 × 1010m−1) and lower affinity (Ka of 1·3–1·9 × 1010m−1) binding sites in each organism. 125I-hLH binding to both S. cerevisiae and N. crassa (wild type) microsomes was inhibited by low concentrations of Ca2+ and Mg2+ (30 μm), and by higher concentrations of Na+ and K+ (40 mm). Binding was also inhibited, in dose-dependent fashion, by partially-purified preparations of hLH and hCG. In contrast, highly purified hCG preparations were much less potent, though they strongly inhibited hLH binding to sheep corpus luteum LH-receptors. Moreover, high-purified hCG β-core protein inhibited hLH binding to S. cerevisiae and N. crassa microsomes in a dose-dependent manner, but had no effect on hLH binding to sheep luteal receptors. The properties of the S. cerevisiae and N. crassa LH-binding sites are similar to those of binders detected previously in Candida albicans. Thus, interactions between hLH-like molecules and their receptors may have a widespread distribution in the Ascomycotina and Deuteromycotina.

Original languageEnglish
Pages (from-to)1229-1234
Number of pages6
JournalMycological Research
Volume98
Issue number11
DOIs
Publication statusPublished - 1994

Funding

This work was supported in part by grants from the MRC, SERC, Wellcome Trust and Glaxo Group Research Ltd. We thank Dr R. A. Radford for providing the N. crassa strains, the Hormone Distribution Officer, NIADD, U.S.A. for the generous gifts of purified ovine gonadotropin and human growth honnone, Drs B. Nisula and D. Blithe, NICHHD, NIH, MD, U.S.A. for purified hCG p-core protein, and Dr S. S. Lynch, Women's Hospital, Birmingham, U.K. for highly purified human pituitary gonadotropins.

FundersFunder number
Glaxo Group Research Ltd.
The Wellcome Trust

ASJC Scopus subject areas

  • Biotechnology
  • Ecology, Evolution, Behavior and Systematics
  • Genetics
  • Plant Science

Fingerprint

Dive into the research topics of 'Specific binding sites for human luteinizing hormone in Neurospora crassa and Saccharomyces cerevisiae'. Together they form a unique fingerprint.

Cite this